Tetra Bio-Pharma Inc. (OTC:TBPMF)
186
Tetra Bio-Pharma is a name that we have written about extensively in this magazine and with good reason as even off it’s highs in June, they are up 300%+ in 2017 and are one of the best performing stocks in the cannabis space. As I noted above, we are seeing a similar continuation wedge forming in this stock as the one Dwight highlighted in the LXRP. Tetra’s wedge is happening farther away from its’ 200 day moving average than LXRP’s so I would consider it ‘higher risk’ from a technical point of view, but that’s because the market hasn’t let it fall as much as it did for Lexaria.